Home
Funding Areas
About Us
Recce Pharmaceuticals Continues Strategic Partnership with Murdoch Children'S Research Institute
Foundation: Pew Charitable Trusts
A synthetic drug being developed for the treatment of life-threatening infections has the potential to become the first new treatment for antibiotic-resistant superbugs in more than 50 years, the New York Times reports.
According to the Pew Charitable Trusts, the drug, called RECCE 327, is the only synthetic polymer and drug candidate in development that has been "approved by the FDA for the treatment of serious and potentially life-threatening infections due to Gram-positive and Gram-negative bacteria, including their superbug forms."
It has also been designated a "Qualified Infectious Disease Product" under the Generating Antibiotic Initiatives Now (GAIN) Act and given 10 years of market exclusivity post approval by the FDA.
But it's not yet approved for use in humans.
"The threat of antibiotic resistance is greater now than ever, and commercial-academic partnerships are crucial to advance antibiotic discovery," Andrew Steer, theme director of infection, immunity, and global health at Murdoch Children's Research Institute in Australia, says in a press release.
"The synergy between our organizations will undoubtedly lead to ground-breaking discoveries that have the potential to transform the landscape of infectious disease treatment."
Recce Pharmaceuticals, which is based in Australia, says its synthetic polymer anti-infectives have the potential to
Selected Grant News Headlines
A customized collection of grant news from foundations and the federal government from around the Web.
'Safety, compassion, innovation': Beaufort Memorial honors top staff at Bemmy Awards.The Quality Services department took home the award for Department of the Year at BeaufortMemorial Hospital's...more
This ranking recognizes the leading children's hospitals in the U.S., featuring the top 50 hospitals.Cleveland Clinic Children's placed in all eight pediatric subspecialities: Cardiology and Cardiac...more
Mackinac Policy Conference left early childhood education off this year's agenda.By 2027, make Detroit a city that puts young children and families first, says James Ribbron, executive director of...more
Investing in tech to help children and communities thrive | Takeda Stories.How our Global CSR Program helped empower diverse entrepreneurs to innovate health solutions.29 Digital public goods...more
Greg Bourke is the author of "Gay, Catholic, and American: My Legal Battle for Marriage Equality and Inclusion" Bourke spoke at the Yale School of Management's Social Impact Lab.Bourke's final advice...more
Tesla plans to deploy a small fleet of robotaxis in Austin in the coming weeks.Tesla FSD 13.2.9 will still run a kid down while illegally blowing past a stopped school bus with red lights flashing...more
Awarded funding will support a wide range of activities between now and September 30, 2025.The FCCN initiative, supported by $85,000 in grant funding, will help build and sustain a Family Child Care...more
The Delivering Innovative Vocational Education through Virtual Reality Technology new workforce training program aimed at preparing individuals with disabilities for the program.DIVE-VRT delivers...more
Children are growing up surrounded by screens, apps, and smart devices.Being intentional about tech use goes a long way toward deepening interest in tech and creating meaningful experiences.Creating...more
Safeguarding innovation and trade secrets in American AI leadership Safeguarded innovation andtrade secrets in U.S.AI leadership.Testimony was given before the House Judiciary Subcommittee on Courts,...more
Children News from...
Becton, Dickinson and Company
Johnson Foundation
Robert Wood Johnson Foundation
Social Entrepreneurship
Spotlight
When it Comes to Social Enterprises, Failure is the Best Platform for Innovation
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.
